白细胞介素-32在化脓性汗腺炎皮损中高表达
本研究比较了化脓性汗腺炎(HS)患者与健康对照及银屑病、特应性皮炎(AD)患者的组织与血清IL-32表达。结果显示HS皮损及血清中IL-32均上调,且皮损中IL32 mRNA水平与干扰素-γ、IL-17A正相关,与IL-13负相关,提示IL-32可能成为HS治疗新靶点。
要点
- HS患者皮损和血清中IL-32表达高于健康对照及AD、银屑病患者。
- HS皮损中IL-32由NK细胞、T细胞、巨噬细胞和树突状细胞表达。
- HS皮损IL32 mRNA与IFN-γ、IL-17A正相关,与IL-13负相关。
核心结论
- IL-32在化脓性汗腺炎中过表达,靶向IL-32可能成为该难治性疾病的新治疗选择。
研究设计与样本
- 获取健康皮肤及HS、银屑病、AD皮损组织,用免疫组化和半定量实时PCR分析IL-32表达。
- 通过双免疫荧光染色确定细胞来源,用ELISA检测四组供者血清IL-32水平。
主要发现
- 与健康对照及AD、银屑病患者相比,HS患者皮损和血清中IL-32均上调。
- HS真皮高浸润区域中NK细胞、T细胞、巨噬细胞和树突状细胞表达IL-32。
- HS皮损中高IL32 mRNA水平与大量T细胞和巨噬细胞一致。
- HS皮损IL32 mRNA水平与干扰素-γ和IL-17A正相关,与IL-13负相关。
临床怎么用
- IL-32可作为HS炎症活动的潜在生物标志物进行进一步评估。
- 靶向IL-32可能为HS提供新的治疗方向,但需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. Its immunopathogenic mechanisms are still poorly understood. Previous studies demonstrated that the proinflammatory cytokine interleukin (IL)-32 is implicated in the pathogenesis of other inflammatory diseases. OBJECTIVES: To investigate the tissue expression and systemic levels of IL-32, as well as its cellular sources, in patients with HS in comparison with healthy donors and patients with two other inflammatory skin diseases: psoriasis and atopic dermatitis (AD). METHODS: Tissue samples were obtained from healthy skin and lesional HS, psoriatic and AD skin to analyse the expression of IL-32 by immunohistochemistry and semiquantitative real-time polymerase chain reaction. The cellular source of the cytokine was determined by double immunofluorescence staining. Serum from the four donor groups was used to measure systemic levels of IL-32 by enzyme-linked immunosorbent assay. RESULTS: IL-32 was upregulated in patients with HS in both lesional skin and serum when compared with healthy donors and patients with AD or psoriasis. In HS, IL-32 was found to be expressed by natural killer cells, T cells, macrophages and dendritic cells in highly infiltrated areas of the dermis. High IL32 mRNA levels in lesional HS skin coincided with high amounts of T cells and macrophages. Additionally, IL32 mRNA levels in lesional HS skin correlate positively with interferon-γ and IL-17A and negatively with IL-13. CONCLUSIONS: Our findings suggest that IL-32 is overexpressed in HS. Targeting IL-32 may therefore represent a new therapeutic option for the treatment of this recalcitrant disease.
引用
- Thomi R, Yerly D, Yawalkar N, et al. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa. Br J Dermatol. 2017. PMID: 28301691. doi:10.1111/bjd.15458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。